Waterbirth versus land birth for low‑risk laboring people
Official title: Trial of Underwater Birth: A Randomized Control Trial
Run by University of New Mexico · NCT07313319 · Data updated 2026-11-12
This project will test if waterbirth reduces the need for epidurals and affects maternal and newborn outcomes for adult low‑risk laboring people compared with giving birth on land.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 230 (estimated) |
| Sponsor | University of New Mexico Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | April 21, 2026 |
| Main results expected | March 2028 |
| Study ends | December 2028 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07313319 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a singleton, vertex pregnancy at term, BMI under 40, able to ambulate and speak English or Spanish, and without major maternal or fetal risk factors are ideal candidates.
✕Probably not a fit
People with high‑risk pregnancies (such as multiples, non‑vertex presentation, preterm labor, significant maternal medical conditions, class III obesity, or active fever/hypertension) or those planning cesarean delivery are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized pilot trial at the University of New Mexico that will assign adult low‑risk laboring people to deliver in water or on land. Eligible participants are term, singleton, vertex pregnancies with BMI <40, able to ambulate and speak English or Spanish, and without major obstetric or medical risk factors; randomization occurs at admission for labor. The primary outcome is use of epidural anesthesia and vaginal birth, with secondary outcomes including IV narcotic use, duration of active labor, mode of delivery, composite maternal and neonatal adverse outcomes, use of intermittent auscultation, and birth satisfaction. Analyses will follow intention‑to‑treat principles and the pilot will inform feasibility and sample size for a larger trial.
Why it matters
Potential benefit: If successful, this approach could reduce epidural use, lower interventions, and improve maternal satisfaction for eligible low‑risk births.
How similar studies have gone: Existing evidence is mostly observational and mixed, with limited randomized data, so this pilot is relatively novel in testing waterbirth in a randomized design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria based on A model practice template for hydrotherapy in labor and birth (2016): Prenatal inclusion criteria (to be assessed at the time of enrollment): * ≥18 years of age * Able to speak and understand English or Spanish * Singleton gestation * Vertex presentation * Able to ambulate with no mobility restrictions (i.e., no difficulty getting from seated to standing) * Less than class III obesity (BMI \<40 kg/m2) at initiation of prenatal care Labor inclusion criteria (to be assessed at time of admission): * Greater than 37 weeks 0 days through and less than 412 completed weeks 6 days gestation with fetus in vertex presentation * Normal blood pressure and normal temperature (obstetric criteria for exclusion: two blood pressures 140/90 four hours apart; two fevers of over 100.4 one hour apart) Exclusion Criteria: based on A model practice template for hydrotherapy in labor and birth (2016): Prenatal exclusion criteria (to be assessed at the time of enrollment): * Active infections such as HIV, Hepatitis B, Hepatitis C, HSV outbreak (on prophylaxis acceptable) (GBS positive is acceptable) * Pre-existing medical conditions including heart disease, uncontrolled asthma, preexisting diabetes, chronic hypertension, or activity restrictions * High-risk pregnancy conditions including preeclampsia, gestational hypertension, preterm gestation, multiple gestation, gestational diabetes type A2, estimated fetal weight of 5000g for non-diabetics or \>4500 for GDM-A1, unstable substance use disorder (i.e. not in remission), placental abruption or other unexplained vaginal bleeding, previous cesarean section, fetal growth restriction (\<10th percentile), fetal anomaly, or other neonatal condition that may complicate neonatal transition to extrauterine life. * Existing contraindication to vaginal birth Labor exclusion criteria (to be assessed at the time of admission): * Meconium-stained amniotic fluid * Preterm rupture of membranes (PROM) greater than 24 hours without the start of any labor contractions (those whose have PROM greater than 24 hours but are in labor can continue to be included in the study) * Immediate need for operative delivery at time of admission
Where it's running
-
University of New Mexico
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Principal investigator: Katrina Nardini — University of New Mexico
- Study coordinator: Family Planning Research
- Email: FamilyPlanningResearch@salud.unm.edu
- Phone: 505-205-4118
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindfulness Text Messages to Support Medication Adherence and Pain Management
This study tests whether daily reminder and mindfulness text messages can help people on medications for opioid use disorder with chronic pain stick to their treatment and better manage cravings and pain.
-
Group psilocybin-assisted therapy for PTSD
This trial will try group psilocybin-assisted therapy to see if it helps adults with moderate to severe PTSD, including veterans, first responders, female survivors of sexual violence, and Indigenous people.
-
Airway Scope vs GlideScope for intubation in patients with BMI 40 or higher
This study tests whether the Airway Scope or GlideScope makes intubation quicker and easier in adults with BMI 40 or more undergoing anesthesia.
-
Text reminders and mindfulness messages to support people taking opioid medications
This project will test whether daily medication reminder texts plus up to six mindfulness messages per day help people taking medications for opioid use disorder stick to their medication and manage cravings, pain, and withdrawal.
-
Home exercise program to improve recovery after vaginal prolapse repair
This research will test whether a 6-week home pelvic floor exercise program helps people having transvaginal prolapse repair get back to normal daily activities after surgery.
-
Heart Health and Nutrition for Life program in Albuquerque
This project tests whether a culturally tailored lifestyle program led by community health workers helps adults with high blood pressure at First Nations Community HealthSource control their blood pressure better than standard care with home monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.